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Although putative bladder cancer families have been pre­
viously described, little is known about the genetic basis of 
this phenomenon. Whether hereditary bladder cancer exists 
as an entity separate from more clearly understood cancer 
family syndromes, such as the Lynch syndrome type II, re­
mains controversial. We identified a potential bladder cancer 
kindred in which the proband was incidentally found to have 
the germline translocation 46 XY, t(5;20)(pl5;qll) in addi­
tion to metachronous transitional cell carcinoma of the upper 
and lower urinary tract.
CASE REPORT
The proband was treated for grade II superficial transi­
tional cell carcinoma of the bladder at age 29 years (fig. 1). 
Subsequently he underwent nephroureterectomy for renal 
pelvic transitional cell carcinoma and is now disease-free. 
His mother had transitional cell carcinoma of the bladder 
and died of metastatic disease at age 65 years. Metastatic 
melanoma developed in the brother of the proband when 
he was 27 years old and he died after a brief disease course.
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The father died of prostate cancer at age 68 years. During 
an evaluation for infertility prompted by multiple sponta­
neous abortions experienced by the wife of the proband, 
the proband was found to have a balanced germline trans­
location (fig. 2 ). Interestingly, his mother had had a h is­
tory of multiple spontaneous abortions but her karyotype 
is not known.
DISCUSSION
Conclusive evidence for the existence of a hereditary form of 
bladder cancer has not been reported. Evidence that transi­
tional cell carcinoma of the ureter occurs within the constella­
tion of the Lynch syndrome type II provides the most convincing 
proof that hereditary transitional cell carcinoma may exist.1 
Although current research suggests that a gene or gene complex 
on chromosome 9 may be the earliest genetic change associated 
with the development of bladder transitional cell carcinoma,2 no 
data link a locus on chromosome 9 to a hereditary form of 
transitional cell carcinoma. The kindred that we identified is 
interesting because of the incidental finding of a balanced germ­
line translocation between the short arm of chromosome 5 and 
the long arm of chromosome 20 in the proband. Although little 
is currently known about the role of chromosomal arm 5p in 
human cancer, 20 q 1 1  to 13 is the location of the c-src oncogene, 
which is over expressed in transitional cell carcinoma.3 Historical
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Fig. 1. Multiple family members from kindred of proband (arrow). 
Brother (IJ) died at age 27 years of melanoma and mother (^) died at 
age 65 years of transitional cell carcinoma (TCC) of bladder.
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Fig. 2. Karotype of proband shows germline translocation at chro­
mosomes 5 (arrow) and 20 (arrow). A total of 20 cells obtained from 
peripheral lymphocyte culture was examined and all had karyotypic 
abnormality, as described.
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data from this family also suggest that the mother of the proband 
may have carried the same balanced translocation in light of her 
history of multiple miscarriages in addition to bladder cancer. The 
fact that cancer was diagnosed in the proband and his brother in 
early adulthood suggests that a familial component to their cancer 
should be considered. Whether genes on chromosome 5p or 20q 
can be implicated in the origin of a familial form of bladder cancer 
awaits the study of larger kindreds.
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